A level IV trauma center in Washington State has installed copper components throughout its facility as another way of reducing hospital-acquired infections and keeping their patients safe.
Pullman Regional Hospital has become an early adopter of antimicrobial copper after studies found that the age-old metal could continuously kill deadly bacteria.
Each year, 2 million people in the United States are diagnosed with a hospital-acquired infection and nearly 100,000 people die. These infections are caused by common bacteria such as E. coli, MRSA, C. diff, CRE and VRE.
“It is a very serious problem,” said Ed Harrich, the director of surgical services for Pullman Regional Hospital. “I think every hospital across the nation is doing everything they can to try to deal with it the best that they can. But there’s bioburden on everything and people aren’t good at hand washing and there’s cross-contamination everywhere you go.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7378651-copper-development-association-cda-pullman-regional-hospital-keep-patients-safe-antimicrobial-copper/
Many women are familiar with the brand name BOTOX® Cosmetic (onabotulinumtoxinA), but a new study from SheSpeaks™, an online community of women, reveals what they really want to know about it.1 To address the most common questions women have – and there are nearly 10 million women who are considering treatment2 – Allergan Inc., maker of BOTOX® Cosmetic, teamed up with SheSpeaks to identify these questions and provide answers.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7334951-allergan-shespeaks-survey-reveals-what-u-s-women-really-want-to-know-about-botox-cosmetic/
AstraZeneca announced today that it has collaborated with actor and father James Van Der Beek on a campaign to dispel common myths about the flu and underscore the importance of annual influenza vaccination for eligible individuals and families. As part of the campaign, Van Der Beek stars in an informative and comedic video, called “Just the Flu Facts,” in which he uses his signature sense of humor to debunk common misconceptions about seasonal influenza that are often barriers to vaccination.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7312451-medimmune-specialty-care-james-van-der-beek-flumist-quadrivalent-encourage-flu-shot/
Volvo Cars’ all-new XC90 – which will be revealed in August – will offer the most comprehensive and technologically sophisticated standard safety package available in the automotive industry. The new technologies will take the company a significant step closer to its vision that no one will be killed or seriously injured in a new Volvo car by 2020.
The XC90 is the first car in the world with technology that features automatic braking if the driver turns in front of an oncoming car. This is a common scenario at busy city crossings as well as on highways, where the speed limits are higher. The all-new Volvo XC90 detects a potential crash and brakes automatically in order to avoid a collision or mitigate the consequences of a crash.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/71400582-all-new-volvo-XC90-safest-car
NI (Nasdaq: NATI) today announced VirtualBench, an all-in-one instrument that integrates a mixed-signal oscilloscope, function generator, digital multimeter, programmable DC power supply and digital I/O. Users interact with VirtualBench through software applications that run on PCs or iPads. The device provides the most common functionality affordably and opens up new possibilities for how engineers can use benchtop instruments.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/7230751-ni-reshapes-instrumentation-with-software-based-device-virtualbench
Jeffrey Bacha, president and CEO of DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) (“DelMar Pharma” or “DelMar”) discusses new clinical research and treatments in development for glioblastoma, the most common and severe form of brain cancer. Less than one out of three patients will survive two years after their diagnosis. DelMar is a cancer-focused company developing new therapies for patients with little to no treatment options.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/7037951-delmar-pharmaceuticals-glioblastoma-brain-tumor-awareness-month
Last-minute tax filers often fall victim to common tax errors either by overpaying a preparer, missing credits/deductions, or making math errors. With the tax filing deadline less than a week away, one of the best ways for eligible tax filers to save money, maximize their refunds and get their refunds quickly is to file for free with MyFreeTaxes.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/7169451-myfreetaxes-non-profit-free-tax-filing
Lung cancer is the most common cause of cancer-related death worldwide, with the highly malignant small cell lung cancer having the worst prognosis. In recent years the surge of immunotherapy has given cancer sufferers new hope.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/65511-issels-integrative-immunotherapy-non-toxic-treatment-lung-cancer
Lung cancer is the most common cause of cancer-related death worldwide, with the highly malignant small cell lung cancer having the worst prognosis. In recent years the surge of immunotherapy has given cancer sufferers new hope.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64826-issels-recurrent-lung-cancer-responds-to-integrative-immunotherapy
Horyou.com, the action-oriented social network for the common good announces its international public beta release. In its first stage, the platform is available to all Internet users in four languages: English, Spanish, Portuguese and French.
Horyou is an international company that promotes a humanistic approach to technology through an online platform that encourages its members to dream, inspire and act.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64173-horyou-new-social-network-public-beta
The first comprehensive long-term study comparing different medications for type 2 diabetes is launching nationwide. The GRADE (Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness) Study will compare the long-term benefits and risks of four widely used diabetes drugs in combination with metformin, the most common first-line medication for treating type 2 diabetes.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64578-grade-glycemia-reduction-approaches-in-diabetes-comparative-effectiveness
Looking to build a new home that would gracefully transition into a full-time, eco-friendly residence, Warren and Sally Baker turned to Blu® Homes, Inc. (“Blu”), the leading builder of precision-engineered, green prefab homes. The Bakers will build a one-story, green home with Blu Homes that is strong enough to weather storms and hurricanes that are common to coastal regions. The Baker home will be Blu Homes’ first project built on Shelter Island.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64404-blu-homes-to-build-first-home-on-shelter-island
